Last reviewed · How we verify

NCT04858672: Surge-ICD

Shock Testing to Unmask RV Lead and GEnerator Malfunction in ICD Patients: the SURGE-ICD Registry

Status unknown Last updated 2 June 2022
What this trial tests

trial in Implantable Defibrillator Lead Dysfunction in 300 participants. Status unknown.

Timeline
23 March 2022
Primary endpoint
15 June 2025
15 June 2025

Quick facts

Lead sponsorUniversitätsklinikum Köln
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date23 March 2022
Primary completion15 June 2025
Estimated completion15 June 2025
Sites1 location across Germany

Conditions studied

Sponsor

Universitätsklinikum Köln — full company profile →

Who can join

18 and older, any sex, with Implantable Defibrillator Lead Dysfunction or Implantable Automatic Defibrillator Malfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Shock testing during ICD generator replacement has been omitted by many centers. A previous study revealed lead failures in internally cardioverted patients with previously normal HV-lead values. The real prevalence of unrecognized "silent" lead failure in ICD patients remains unknown. As a consequence, patients may be equipped with an ICD which is unable to provide life-saving shocks. The proposed registry aims to include patients presenting for ICD generator replacement or electrical cardioversion of atrial arrhythmia. The protocol mandates either a commanded synchronized high energy shock prior to generator replacement or internal cardioversion of atrial arrhythmia to provoke the unmasking of silent lead failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universitätsklinikum Köln trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04858672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing